Dyne was founded with a singular focus: to deliver life-transforming therapies for people living with serious muscle diseases. We are utilizing our proprietary FORCE™ platform to overcome limitations of muscle tissue delivery and advance modern oligonucleotide therapeutic candidates. We have assembled an exceptional team with deep experience in muscle disease, rare disorders, drug development and manufacturing and commercialization of novel therapeutics. We have also established a scientific advisory board comprised of leading experts in the fields of muscle disease drug discovery and development and nucleic acid therapeutics, who share our mission.

Because together, we are stronger.